← Insider Monitor
Pluri Inc. logo
PLUR

Pluri Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Pluri Inc. develops cell-based technologies, using its proprietary cell expansion platform to grow placental and other cells for potential applications in cell therapy, food ingredients, and biomaterials.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Haifa
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Manieu Alexandre WeinsteinDirectorBuy$1.25MOct 23, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for PLUR.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable PLUR activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.